EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

How I do it: > 8 Carmustine wafer implantation during supra-marginal resection of a glioblastoma, IDH-wildtype

Alexandre Roux, Angela Elia, Marc Zanello, Johan Pallud

Acta Neurochirurgica · 2025

DOI: 10.1007/s00701-025-06675-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurochirurgica, 2025. Verfasst von Alexandre Roux und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service de Neurochirurgie, GHU-Paris Psychiatrie Et Neurosciences, Site Sainte Anne, Paris, F-75014, France. alexandre.roux@neurochirurgie.fr. Hauptthemen laut MEDLINE: Antineoplastic Agents, Alkylating, Brain Neoplasms, Carmustine, Glioblastoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The maximal safe resection of glioblastoma, IDH-wildtype often creates a large resection cavity that can accommodate more than eight Carmustine implants. METHOD: We detail the implantation technique of 13 Carmustine wafers within the surgical bed after a right hippocampal formation-sparing anterior temporal lobectomy allowing for the supra-marginal resection of a glioblastoma IDH-wildtype in an adult patient. CONCLUSION: Carmustine wafer implantation is a safe and efficient technique following surgical resection of a glioblastoma, IDH-wildtype. Sequential technical steps are required to improve the safety and the efficacy of Carmustine wafer implantation. More than eight Carmustine wafers could be implanted in large surgical cavities with survival benefits for the patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, AlkylatingBrain NeoplasmsCarmustineGlioblastomaNeurosurgical ProceduresHumansDrug ImplantsIsocitrate DehydrogenaseAdult

Stichwörter der Autor:innen

IDH-wildtypeCarmustine wafer implantationGlioblastomaNeurosurgery

Substanzen

Antineoplastic Agents, AlkylatingCarmustineDrug ImplantsIsocitrate Dehydrogenase

Autor:innen und Institutionen

  • Service de Neurochirurgie, GHU-Paris Psychiatrie Et Neurosciences, Site Sainte Anne, Paris, F-75014, France. alexandre.roux@neurochirurgie.fr.
  • Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-Brain, Paris, F-75014, France. alexandre.roux@neurochirurgie.fr.
  • Service de Neurochirurgie, GHU-Paris Psychiatrie Et Neurosciences, Site Sainte Anne, Paris, F-75014, France.
  • Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-Brain, Paris, F-75014, France.

Zitieren

APA

Roux, A., Elia, A., Zanello, M., & Pallud, J. (2025). How I do it: > 8 Carmustine wafer implantation during supra-marginal resection of a glioblastoma, IDH-wildtype. Acta Neurochirurgica. https://doi.org/10.1007/s00701-025-06675-5

Vancouver

Roux A, Elia A, Zanello M, Pallud J. How I do it: > 8 Carmustine wafer implantation during supra-marginal resection of a glioblastoma, IDH-wildtype. Acta Neurochirurgica. 2025. doi:10.1007/s00701-025-06675-5

BibTeX
@article{Roux2025,
  author = {Roux, Alexandre and Elia, Angela and Zanello, Marc and Pallud, Johan},
  title = {How I do it: > 8 Carmustine wafer implantation during supra-marginal resection of a glioblastoma, IDH-wildtype},
  journal = {Acta Neurochirurgica},
  year = {2025},
  doi = {10.1007/s00701-025-06675-5}
}
Kostenlos starten →